Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
NCT06669949 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2025-05-13
Summary
This is a prospective longitudinal natural history study with a retrospective cross-sectional arm aimed at determining the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS), a recently recognized inborn error of metabolism. The central hypothesis is that age of onset, other disease features, and disease biomarkers will be predictive of quality of life (QOL) and survival in SPLIS patients.
Conditions
- Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
Interventions
- OTHER
-
no intervention
No interventions are involved in this observational study.
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Julie D Saba, MD, PhD · University of California, San Francisco
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-22
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
Prenatal Screening For Smith-Lemli-Opitz Syndrome
NCT00070850 ·Status: COMPLETED
-
The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
NCT05705674 ·Status: RECRUITING
-
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
NCT01938014 ·Status: COMPLETED
-
Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency
NCT02193867 ·Status: TERMINATED ·Phase: PHASE2
-
Registry of Patients Diagnosed With Lysosomal Storage Diseases
NCT05619900 ·Status: RECRUITING
-
A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA; Sanfilippo Syndrome)
NCT05523206 ·Status: COMPLETED
-
ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
NCT05368038 ·Status: ENROLLING_BY_INVITATION
-
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
NCT04532047 ·Status: RECRUITING ·Phase: PHASE1
-
Estimation of the Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans
NCT00017732 ·Status: COMPLETED
-
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
NCT00064792 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
NCT05825131 ·Status: RECRUITING
-
Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)
NCT03612869 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder
NCT02234024 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients
NCT03423186 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis
NCT04112602 ·Status: COMPLETED
-
AVTX-801 D-galactose Supplementation in SLC35A2-CDG
NCT05402384 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
NCT01123863 ·Status: COMPLETED
-
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
NCT02060526 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Enzyme Replacement in Gaucher's Disease
NCT00001289 ·Status: COMPLETED
-
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
NCT05371613 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)
NCT01822184 ·Status: COMPLETED
-
Investigating Lysosomal Storage Diseases in Minority Groups
NCT02120235 ·Status: UNKNOWN
-
SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
NCT01434745 ·Status: TERMINATED ·Phase: NA
-
Cellular Pharmacodynamics of Small Molecules in Lysosomal Storage Disorders
NCT03812055 ·Status: UNKNOWN
-
Study of Metabolic Modifications in Children With Noonan Syndrome
NCT02383316 ·Status: COMPLETED ·Phase: NA